Please assess the completion status of the following clinical trial:

Trial Title: ACute and Chronic Effects of Saxagliptin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Social security affiliation~* Persons without TUTORSHIP that can freely agree to participate to the study~* Age between 18 to 70 years~* Impaired glucose tolerance diagnosed during the previous month.~Exclusion criteria:~* Pregnancy~* Breast feeding~* Diabetes~* No contraception~* Body Mass Index \> 45 kg/m²~* Arterial blood pressure \> 160/110 mmHg~* Creatinine clearance \< 60 ml/min~* Severe hepatocellular insufficiency~* Chronic respiratory disease~* Anaemia (Hemoglobin \< 10 g/dl)~* Peripheral arterial occlusive disease~* Heart failure~* Cardiac arrhythmia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Saxagliptin (Type: EXPERIMENTAL): Saxagliptin 5 mg (tablet) at BREAKFEAST
- placebo pill (Type: PLACEBO_COMPARATOR): at BREAKFEAST

Based on this trial design, predict the completion outcome and termination type (if applicable).